Literature DB >> 35110233

Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease.

Ana Filipa Santos Duarte de Figueiredo1, João Felício Costa1, António P Matos1, Miguel Ramalho1.   

Abstract

OBJECTIVE: To determine the predictive value of esophageal dilatation as observed in high-resolution computed tomography (HRCT) for the diagnosis of systemic sclerosis (SSc) in patients with interstitial lung disease (ILD).
METHODS: Our sample consisted of patients diagnosed with SSc and proven interstitial lung involvement with available HRCT exams (n = 20). Individuals with other forms of rheumatic ILD were included as a control group (n = 20). Two blinded radiologists independently reviewed the images for the presence of esophageal dilatation, measured at 3 different levels. Interobserver agreement was tested with Lin's concordance correlation coefficient (CCC). Independent t-test was used to compare maximum esophageal diameters between groups. Friedman's test was used to evaluate differences between the 3-level measurements. Receiver operating characteristic analysis was performed.
RESULTS: There was a substantial correlation between both readers (CCC = 0.9802-0.9919). Esophageal dilatation was significantly associated with SSc (P = .0012). The optimal calculated cut-off value to differentiate SSc from other ILDs was 18.5 mm (sensitivity and specificity of 70 and 90%, respectively; area under the curve 0.819), measured 1 cm above the diaphragmatic hiatus.
CONCLUSION: HRCT may have a discriminative role in the presence of both ILD and esophageal dilatation for the diagnosis of SSc. Our results suggest that a cut-off value for the esophageal diameter of 18.5 mm might propose the diagnosis of SSc with reasonable confidence.

Entities:  

Year:  2021        PMID: 35110233      PMCID: PMC8975317          DOI: 10.5152/TurkThoracJ.2021.19162

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  19 in total

1.  Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: what does it signify?

Authors:  Anoop Kumar Pandey; Pearce Wilcox; John R Mayo; Robert Moss; Jennifer Ellis; Jacquie Brown; Arvind Kavishwar; Jonathon Leipsic
Journal:  J Med Imaging Radiat Oncol       Date:  2011-12       Impact factor: 1.735

2.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

3.  High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.

Authors:  Sumawadee Patiwetwitoon; Suparaporn Wangkaew; Juntima Euathrongchit; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  J Clin Rheumatol       Date:  2012-08       Impact factor: 3.517

4.  Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy.

Authors:  M Bhalla; R M Silver; J A Shepard; T C McLoud
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

5.  Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Paolo Fraticelli; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2018-04-23       Impact factor: 3.469

6.  Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value.

Authors:  Serena Vettori; Salvatore Tolone; Domenico Capocotta; Rossella Chieffo; Veronica Giacco; Gabriele Valentini; Ludovico Docimo
Journal:  Clin Rheumatol       Date:  2018-02-13       Impact factor: 2.980

Review 7.  Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.

Authors:  Romy B Christmann; Athol U Wells; Vera L Capelozzi; Richard M Silver
Journal:  Semin Arthritis Rheum       Date:  2010-05-21       Impact factor: 5.532

8.  Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.

Authors:  Carrie Richardson; Rishi Agrawal; Jungwha Lee; Orit Almagor; Ryan Nelson; John Varga; Michael J Cuttica; Jane D Amico Dematte; Rowland W Chang; Monique E Hinchcliff
Journal:  Semin Arthritis Rheum       Date:  2016-02-26       Impact factor: 5.532

Review 9.  Evaluation and management of gastrointestinal manifestations in scleroderma.

Authors:  Donald F Kirby; Soumya Chatterjee
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

Review 10.  Evaluation and management of esophageal manifestations in systemic sclerosis.

Authors:  Konstantinos Denaxas; Spyros D Ladas; George P Karamanolis
Journal:  Ann Gastroenterol       Date:  2018-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.